期刊文献+

人类激肽释放酶2研究进展及其与前列腺癌的关系 被引量:6

原文传递
导出
摘要 前列腺癌(prostaticcarcinoma,PCa)是欧美地区男性最常见的恶性肿瘤,在美国居所有恶性肿瘤的第一位,病死牢居第二位,仅次于肺癌…。随着老龄化社会的到来和饮食结构的改变,我国人群前列腺癌的发病率呈逐年上升的趋势。南于前列腺癌生长缓慢,早期常无明显症状。发现时多属晚期,预后不良,冈此早期诊断前列腺癌对其治疗及预后具有重要意义。
出处 《中华临床医师杂志(电子版)》 CAS 2012年第8期130-132,共3页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献25

  • 1Jemal A,Bray F,Center MM. Global cancer statistics[J].CA:A Cancer Journal for Clinicians,2011.69-90.doi:10.3322/caac.20107.
  • 2Macefield RC,Lane JA,Metcalfe C. Do the risk factors of age,family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy[J].European Journal of Cancer,2009.2569-2573.
  • 3Shariat SF,Semjonow A,Lilja H. Tumor markers in prostate cancer I:blood-based markers[J].Acta Oncologica,2011.61-75.
  • 4Jansen FH,Roobol M,Jenster G. Screening for prostate cancer in 2008 II:the importance of molecular subforms of prostate-specific antigen and tissue kallikreins[J].European Urology,2009.563-574.
  • 5Vickers AJ,Cronin AM,Roobol MJ. A four-kallikrein panel predicts prostate cancer in men with recent screening:data from the European Randomized Study of Screening for Prostate Cancer,Rotterdam[J].Clinical Cancer Research,2010.3232-3239.
  • 6Steuber T,Vickers AJ,Haese A. Risk assessment for biochemical recurrence prior to radical prostatectomy:significant enhancement contributed by human glandular kallikrein 2(hK2)and free prostate specific antigen(PSA)in men with moderate PSA-elevation in serum[J].International Journal of Cancer,2006.1234-1240.
  • 7Thompson IM,Ankerst DP,Chi C. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower[J].Journal of the American Medical Association,2005.66-70.
  • 8Haroun AA,Hadidy AS,Awwad ZM. Utility of free prostate specific antigen serum level and its related parameters in the diagnosis of prostate cancer[J].Saudi J Kidney Dis Transpl,2011.291-297.
  • 9Vickers AJ,Cronin AM,Aus G. A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer:data from the European Randomized Study of Prostate Cancer Screening in Gteborg,Sweden[J].BMC Medicine,2008.19.doi:10.1186/1741-7015-6-19.
  • 10Raaijmakers R,de Vries SH,Blijenberg BG. hK2 and free PSA,a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml[J].European Urology,2007.1358-1364.

同被引文献39

  • 1申景涛,郭万华,辛小燕,贾支俊,徐佩,施鸣.PSAD,tPSA,fPSA/tPSA在前列腺癌“诊断灰色带”中的ROC曲线分析[J].现代检验医学杂志,2007,22(5):59-61. 被引量:10
  • 2Fried NM, Murray KE. High-power thulium fiber laser ablation of urinary tissues at 1.94 micrometers. JEndourol 2005; 19(1): 25-31.
  • 3Bach T, Herrmann TR, Ganzer R, et al. RevoLix vaporesection of the prostate:initial results of 54 patients with a 1-year follow-up. WorldJUro12007;25(3): 257-262.
  • 4Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA CancerJClin 2013; 63(1): 11-30.
  • 5Mamoulakis C, Schulze M, Skolarikos A, eta1. Midterm results from an international multicentre randomised controlled trial comparing bipolar with monopolar transurethral resection of the prostate. Eur Uro12013; 63(4): 667-676.
  • 6Bach T, Herrmann TR, Cellarius C, et al. Bladder neck incision using a 70W, 2 micron continuous wave laser (RevoLix). WorldJUro12007; 25(3): 263-267.
  • 7Bach T, Huck N, Wezel F, et al. 70 vs 120 ,W thulium:yttrium-aluminium-garnet 2 microm continuous- wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation. BJUlnt 2010; 106(3): 368-372.
  • 8Wendt-Nordahl G, Huckele S, Honeck P, et al. Systematic evaluation of a recently introduced 2-microm continuous- wave thulium laser for vaporesection of the prostate. J Endouro12008; 22(5): 1041-1045.
  • 9沈默,陶志华,周平,李澄棣,陈伟,吴秀玲.血清前列腺特异抗原和前列腺特异抗原密度对前列腺癌诊断价值评价[J].浙江临床医学,2008,10(2):152-153. 被引量:10
  • 10叶宗岳,李贤新,来永庆,吴雄辉,黄姗姗,关志忱,叶炯贤.前列腺特异性抗原(PSA)及其相关参数在PSA灰区诊断前列腺癌的临床研究[J].国际泌尿系统杂志,2009,29(5):577-581. 被引量:4

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部